Instil Bio Statistics
Total Valuation
Instil Bio has a market cap or net worth of $51.54 million. The enterprise value is $61.48 million.
| Market Cap | 51.54M |
| Enterprise Value | 61.48M |
Important Dates
The last earnings date was Friday, May 15, 2026, before market open.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Instil Bio has 6.78 million shares outstanding. The number of shares has increased by 3.27% in one year.
| Current Share Class | 6.78M |
| Shares Outstanding | 6.78M |
| Shares Change (YoY) | +3.27% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.02% |
| Owned by Institutions (%) | 18.13% |
| Float | 3.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.46 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 39.87, with a Debt / Equity ratio of 0.77.
| Current Ratio | 39.87 |
| Quick Ratio | 15.79 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.07 |
Financial Efficiency
Return on equity (ROE) is -37.07% and return on invested capital (ROIC) is -13.00%.
| Return on Equity (ROE) | -37.07% |
| Return on Assets (ROA) | -12.69% |
| Return on Invested Capital (ROIC) | -13.00% |
| Return on Capital Employed (ROCE) | -22.71% |
| Weighted Average Cost of Capital (WACC) | 9.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.79M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.07% in the last 52 weeks. The beta is 1.91, so Instil Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.91 |
| 52-Week Price Change | -73.07% |
| 50-Day Moving Average | 8.11 |
| 200-Day Moving Average | 11.69 |
| Relative Strength Index (RSI) | 25.54 |
| Average Volume (20 Days) | 21,025 |
Short Selling Information
The latest short interest is 232,840, so 3.43% of the outstanding shares have been sold short.
| Short Interest | 232,840 |
| Short Previous Month | 231,366 |
| Short % of Shares Out | 3.43% |
| Short % of Float | 6.43% |
| Short Ratio (days to cover) | 7.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -44.45M |
| Pretax Income | -47.38M |
| Net Income | -47.38M |
| EBITDA | -44.40M |
| EBIT | -44.45M |
| Earnings Per Share (EPS) | -$7.04 |
Balance Sheet
The company has $74.57 million in cash and $85.19 million in debt, with a net cash position of -$10.61 million or -$1.57 per share.
| Cash & Cash Equivalents | 74.57M |
| Total Debt | 85.19M |
| Net Cash | -10.61M |
| Net Cash Per Share | -$1.57 |
| Equity (Book Value) | 110.70M |
| Book Value Per Share | 16.32 |
| Working Capital | 183.58M |
Cash Flow
| Operating Cash Flow | -33.76M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 48,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -33.76M |
| FCF Per Share | -$4.98 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Instil Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.27% |
| Shareholder Yield | -3.27% |
| Earnings Yield | -93.14% |
| FCF Yield | -66.37% |
Analyst Forecast
The average price target for Instil Bio is $7.00, which is -7.89% lower than the current price. The consensus rating is "Hold".
| Price Target | $7.00 |
| Price Target Difference | -7.89% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Dec 8, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |